Skip to content
healthcare.dev

euqate nicotine

NDC 79903-101, Nicotine Polacrilex, lozenge, from WALMART INC..

Product NDC
79903-101
Status
Listed
Labeler
WALMART INC.
Dosage form
LOZENGE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA077007
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/79903-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NICOTINE2 mg/1

Pharmacologic classes

Cholinergic Nicotinic Agonist [EPC]; Nicotine [CS]

Package NDCNDC-11Package
79903-101-20799030101201 CONTAINER in 1 CARTON (79903-101-20) / 20 LOZENGE in 1 CONTAINER
79903-101-407990301014040 LOZENGE in 1 CONTAINER (79903-101-40)
79903-101-80799030101802 CONTAINER in 1 CARTON (79903-101-80) / 40 LOZENGE in 1 CONTAINER

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 79903-101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/79903-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 79903-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.